Intra-articular triamcinolone: new indication. Juvenile idiopathic arthritis: several months of relief.
Effective in more than three-quarters of children for at least 6 months after the injection. Caution about the risk of systemic adverse effects, especially in cases of repeated use.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007270:Injections, Intra-Articular; D013997:Time Factors; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014221:Triamcinolone